ES8305352A1 - Procedimiento para la preparacion de nuevos compuestos de aorilimidazol-2-ona. - Google Patents

Procedimiento para la preparacion de nuevos compuestos de aorilimidazol-2-ona.

Info

Publication number
ES8305352A1
ES8305352A1 ES510087A ES510087A ES8305352A1 ES 8305352 A1 ES8305352 A1 ES 8305352A1 ES 510087 A ES510087 A ES 510087A ES 510087 A ES510087 A ES 510087A ES 8305352 A1 ES8305352 A1 ES 8305352A1
Authority
ES
Spain
Prior art keywords
aroylimidazolones
novel
aroylimidazole
cardiotonics
ones
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES510087A
Other languages
English (en)
Other versions
ES510087A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of ES510087A0 publication Critical patent/ES510087A0/es
Publication of ES8305352A1 publication Critical patent/ES8305352A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Luminescent Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE COMPUESTOS DE AROILIMIDAZOL-2-ONA, DE FORMULA GENERAL (I), EN LA QUE Q Y T SON CADA UNO DE ELLOS UN ATOMO DE OXIGENO O UN ATOMO DIVALENTE DE AZUFRE; R ES HIDROGENO, ALQUILO INFERIOR O BENZOILO; R ES HIDROGENO O ALQUILO INFERIOR; Y AR ES PIRIDILO, PIRRILO, TIENILO O FURANILO, Y SUS SALES DE ADICION FARMACEUTICAMENTE ACEPTABLES. CONSISTE EN HACER REACCIONAR UNA AMINOCETONA DE FORMULA (II), EN LA QUE R Y AR TIENEN LOS SIGNIFICADOS YA INDICADOS, CON UNA SAL DE CIANATO O TIOCIANATO. DE APLICACION COMO CARDIOTONICOS EN EL TRATAMIENTO DE FALLOS CARDIACOS.
ES510087A 1981-03-05 1982-03-03 Procedimiento para la preparacion de nuevos compuestos de aorilimidazol-2-ona. Expired ES8305352A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24088981A 1981-03-05 1981-03-05
US06/314,312 US4405628A (en) 1981-03-05 1981-10-23 4-Pyridylimidazolones and method of use

Publications (2)

Publication Number Publication Date
ES510087A0 ES510087A0 (es) 1983-04-16
ES8305352A1 true ES8305352A1 (es) 1983-04-16

Family

ID=26933806

Family Applications (2)

Application Number Title Priority Date Filing Date
ES510087A Expired ES8305352A1 (es) 1981-03-05 1982-03-03 Procedimiento para la preparacion de nuevos compuestos de aorilimidazol-2-ona.
ES519254A Expired ES8402827A1 (es) 1981-03-05 1983-01-25 Procedimiento para la preparacion de nuevos compuestos de aroilimidazol-2-ona.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES519254A Expired ES8402827A1 (es) 1981-03-05 1983-01-25 Procedimiento para la preparacion de nuevos compuestos de aroilimidazol-2-ona.

Country Status (18)

Country Link
US (1) US4405628A (es)
EP (1) EP0059948B1 (es)
KR (1) KR890000765B1 (es)
AT (1) ATE16489T1 (es)
AU (1) AU557590B2 (es)
CA (1) CA1190550A (es)
DE (1) DE3267352D1 (es)
DK (1) DK168627B1 (es)
ES (2) ES8305352A1 (es)
GB (1) GB2096600B (es)
GR (1) GR76518B (es)
HK (1) HK61686A (es)
IE (1) IE52387B1 (es)
IL (1) IL65137A (es)
MY (1) MY8600700A (es)
NO (1) NO157175C (es)
NZ (1) NZ199885A (es)
PH (1) PH18345A (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4367236A (en) * 1981-11-04 1983-01-04 Merrell Dow Pharmaceuticals Inc. Method for the treatment of cardiac failure with alkanoylimidazol-2-one derivatives
US4552880A (en) * 1983-02-15 1985-11-12 Merrell Dow Pharmaceuticals Inc. Aroylimidazolones
US4532250A (en) * 1983-11-23 1985-07-30 American Hospital Supply Corporation 5-Heteroarylimidazol-2-ones having cardiotonic activity
US4556665A (en) * 1984-07-09 1985-12-03 Schering A.G. Cardiotonic 1,3-dihydro-4-[[(imidazol-1-yl)aryl]carbonyl]imidazol-2-ones
IL75902A (en) * 1984-07-30 1988-10-31 Merrell Dow Pharma Preparation of 1,3-dihydro-4-pyridoyl-2h-imidazol-2-ones
US4803278A (en) * 1984-07-30 1989-02-07 Merrell Dow Pharmaceuticals, Inc. Preparation of 1,3-dihydro-4-pyridoyl-2H-imidazol-2-ones
ZA881807B (en) * 1987-03-20 1988-09-05 Merrell Dow Pharmaceuticals Inc. Method for reducing reperfusion injury with imidazol-2-thiones
US4999365A (en) * 1987-03-20 1991-03-12 Merrell Dow Pharmaceuticals Inc. Method of reducing reperfusion injury with imidazol-2-thiones
ZA887662B (en) * 1987-10-19 1989-06-28 Merrell Dow Pharma Method for reducing reperfusion injury with imidazol-2-thione-carboxamides
EP0536279A1 (en) * 1990-06-29 1993-04-14 The Upjohn Company Substituted 1-(alkoxyphenyl)piperazines with cns and antihypertensive activity
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US7879802B2 (en) 2007-06-04 2011-02-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
MX357121B (es) 2011-03-01 2018-06-27 Synergy Pharmaceuticals Inc Star Proceso de preparacion de agonistas c de guanilato ciclasa.
CA2902348C (en) 2013-02-25 2021-11-30 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
BR112015030326A2 (pt) 2013-06-05 2017-08-29 Synergy Pharmaceuticals Inc Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos
WO2015021358A2 (en) 2013-08-09 2015-02-12 Dominique Charmot Compounds and methods for inhibiting phosphate transport
US20200368223A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Methods for inhibiting phosphate transport

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2441933A (en) * 1945-07-30 1948-05-18 Hoffmann La Roche Substituted imidazolones and process of making them
US3538104A (en) * 1969-02-28 1970-11-03 Geigy Chem Corp Pyridyl-2-imidazolones
ZA803332B (en) * 1979-06-18 1981-01-28 Richardson Merrell Inc Novel 4-aroylimidazol-2-ones
NZ193935A (en) * 1979-06-18 1985-05-31 Richardson Merrell Inc 4-aroyl-imidazol-2-one derivatives;pharmaceutical compositions
PH18106A (en) * 1981-02-18 1985-03-21 Merrell Dow Pharma Novel-4-aroylimidazol-2-ones

Also Published As

Publication number Publication date
IL65137A (en) 1987-02-27
KR890000765B1 (ko) 1989-04-05
EP0059948A1 (en) 1982-09-15
ES510087A0 (es) 1983-04-16
US4405628A (en) 1983-09-20
AU8103782A (en) 1982-09-09
ES519254A0 (es) 1984-03-01
IE52387B1 (en) 1987-10-14
PH18345A (en) 1985-06-05
NO820686L (no) 1982-09-06
DK168627B1 (da) 1994-05-09
GR76518B (es) 1984-08-10
HK61686A (en) 1986-08-29
IE820491L (en) 1982-09-05
CA1190550A (en) 1985-07-16
DK95482A (da) 1982-09-06
AU557590B2 (en) 1986-12-24
GB2096600A (en) 1982-10-20
GB2096600B (en) 1985-06-05
DE3267352D1 (en) 1985-12-19
ATE16489T1 (de) 1985-11-15
NZ199885A (en) 1985-04-30
NO157175C (no) 1988-02-03
IL65137A0 (en) 1982-05-31
ES8402827A1 (es) 1984-03-01
KR830009046A (ko) 1983-12-17
NO157175B (no) 1987-10-26
MY8600700A (en) 1986-12-31
EP0059948B1 (en) 1985-11-13

Similar Documents

Publication Publication Date Title
ES8305352A1 (es) Procedimiento para la preparacion de nuevos compuestos de aorilimidazol-2-ona.
GB2133973B (en) Improvements relating to the positioning of equipment, such as medical equipment
IL66256A0 (en) Water containing compositions comprising salts of n-substituted-2-pyrrolidone-4-carboxylic acids as humectants
ES468525A1 (es) Procedimiento para la obtencion de nuevas 2-alquilenaminodi-hidropiridinas
ATE7387T1 (de) Herstellung des calciumsalzes von alpha-hydroxy- gamma-methylmercaptobuttersaeure.
GR3005481T3 (es)
CA1269383C (en) HERBICIDAL ESTERS OF 2,6-BIS-FLUOROMETHYLDIHYDROPYRIDINE-3,5-DICARBOXYLIC ACID
EP0167936A3 (en) Use of actinonin as an immunopotentiator
DE3686472D1 (de) Cardiotonische phenyloxazolone.
ES2000594A6 (es) Un procedimiento para la preparacion de tiazolonas
JPS56167636A (en) Use of 4-phenyl-4-oxy-2-hydroxybutanoic acid substitution derivative as drug
ES8505351A1 (es) Un procedimiento para preparar nuevas aroilimidazolonas
ES8507530A1 (es) Un procedimiento para la preparacion de aricoxicicloalcanolaminolaminoalquilen-aril-cetonas.
ATE69609T1 (de) Cardiotonische imidazolylphenylpyrrol-2-one.
MY102063A (en) New use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins
ES8507116A1 (es) Un procedimiento para preparar un alcoxiimino eter
JPS5283944A (en) Pharmaceutical composition useful as treatment of aphthaic stomatitis

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20020304